BONORA, Stefano

BONORA, Stefano  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 397 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load 2010 Calcagno A; Milia MG; D'Avolio A; Ndayishimiyae P; Dusabimana P; Bonora S; Cusato J; Simiele M; Rostagno R; Siccardi M; Audagnotto S; Ghisetti V; Di Perri G.
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. 2011 A. D'Avolio;M. Simiele;M. Siccardi;L. Baietto;M. Sciandra;V. Oddone;F. R. Stefani;S. Agati;J. Cusato;S. Bonora;G. Di Perri
A LC-MS method to quantify tenofovir urinary concentrations in treated patients 2015 Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio
A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. 2015 D'Ascenzo F;Quadri G;Cerrato E;Calcagno A;Omedè P;Grosso Marra W;Abbate A;Bonora S;Biondi Zoccai G;Moretti C;Gaita F
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients 2008 Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de; Stefano Bonora; Giovanni Di Perri
A new HPLC method to measure plasma levels of enfuvirtide (ENF or T-20) 2004 D'Avolio A.; Sciandra M.; Bonora S.; Ibanez A.; Marucco D.; Di Perri G.
A new validated Solid Phase Extraction (SPE)-HPLC method to measure plasma concentrations of tenofovir 2004 D'Avolio A.; Sciandra M.; Bonora S.; Boffito M.; Canta F.; De Requena D.; Di Perri G.
A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients. 2008 Bonora S; D'Avolio A; Tettoni C; Siccardi M; Gonzalez de Requena D; Baietto L; Cometto C; Sciandra M; Trentini L; Di Perri G.
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease 2008 Giovanni Guaraldi; Stefania Cocchi; Alice Motta; Sara Ciaffi; Mauro Codeluppi; Stefano Bonora; Fabrizio Di Benedetto; Michele Masetti; Marco Floridia; Silvia Baroncelli; Diego Pinetti; Antonio D'Avolio; Alfio Bertolini; Roberto Esposito
A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance 2009 Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A
A Population Pharmacokinetic Model Illustrates an Association Between a Pregnane-X-Receptor (PXR) Polymorphism and Boosted Atazanavir Clearance 2010 Schipani A; Siccardi M; Boffito M; D’Avolio A; Bonora S; Davies G; Khoo S; Back D; Di Perri G; Owen A
A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 2015 Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; D'Avolio, Antonio; De Rosa, Francesco Giuseppe; Bonora, Stefano
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients. 2011 M. Lanzafame;S. Bonora;E. Lattuada;A. Calcagno;S. Vento
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs 2020 Ilaria De Benedetto, Mattia Trunfio, Giulia Guastamacchia, Stefano Bonora, Andrea Calcagno
A Simple and Fast Method for Quantification of Ertapenem using Meropenem as Internal Standard in Human Plasma in a Clinical Setting 2008 D'AVOLIO A; BAIETTO L; DE ROSA FG; GARAZZINO S; SCIANDRA M; SICCARDI M; BONORA S; DI PERRI G
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method 2007 D'AVOLIO A; SCIANDRA M; SICCARDI M; BAIETTO L; DE REQUENA DG; BONORA S; DI PERRI G
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs 2015 Baietto, Lorena; Calcagno, Andrea; Motta, Ilaria; Baruffi, Katia; Poretti, Viviana; Di Perri, Giovanni; Bonora, Stefano; D'Avolio, Antonio
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. 2010 A. D'Avolio;M. Simiele;L. Baietto;M. Siccardi;M. Sciandra;S. Patanella;S. Bonora;G. Di Perri
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma 2014 Marco Simiele;Lorena Baietto;Alessio Audino;Mauro Sciandra;Stefano Bonora;Giovanni Di Perri;Antonio D’Avolio
Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients 2007 WATERS L.J; MOYLE G; BONORA S; D'AVOLIO A; ELSE L; MANDALIA S; POZNIAK A; NELSON M; GAZZARD B; BACK D; BOFFITO M